# Genotype–phenotype interaction in Alzheimer's disease immune activation

**Authors:** Stephanie Knudtzon, Bjørn‐Eivind Kirsebom, Lene Pålhaugen, Francesco Bettella, Berglind Gísladóttir, Shahram Bahrami, Lavinia Athanasiu, Arvid Rongve, Arne Nakling, Ina S. Almdahl, Lisa Kalheim, Jonas Alexander Jarholm, Gøril Rolfseng Grøntvedt, Ragnhild Eide Skogseth, Dag Aarsland, Knut Waterloo, Ole A. Andreassen, Tormod Fladby, Kaja Nordengen

PMC · DOI: 10.1002/alz.70978 · Alzheimer's & Dementia · 2026-01-09

## TL;DR

This study explores how genetic risk factors for Alzheimer's disease influence immune responses in the brain, especially when neurodegeneration is present.

## Contribution

The study introduces immune-related polygenic risk scores to analyze genotype-phenotype interactions in Alzheimer's immune activation.

## Key findings

- High AD PRSINFL scores correlate with lower levels of sTREM2, clusterin, and fractalkine in individuals with elevated t-tau.
- High sum PRSIMMUNE scores correlate with lower clusterin in individuals with elevated NfL.
- Genetic predisposition for immune activation may lead to unfavorable immune responses in early Alzheimer's disease.

## Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder influenced by genetic factors, particularly related to immune activation. This study examines genotype‐phenotype interactions affecting immune responses in AD as a reaction to neurodegeneration.

We computed AD polygenic risk scores (PRSs) informed by shared AD‐autoimmunity genetics (AD PRSINFL), AD‐independent immune activation score from 10 autoimmune diseases (sum PRSIMMUNE), and standard AD PRSs for 294 individuals. Cerebrospinal fluid (CSF) immune markers (sTREM2, clusterin, fractalkine, and chitinase 3 like protein (YKL‐40)) were regressed on PRSs, and their interaction with neurodegeneration markers (total tau [t‐tau] or neurofilament light chain [NfL]).

High AD PRSINFL scores correlated with lower sTREM2 (β = −0.18, p < 0.01), clusterin (β = −0.12, p < 0.05), and fractalkine (β = −0.13, p < 0.05) levels in cases with elevated t‐tau. High sum PRSIMMUNE score correlated with lower clusterin in cases with elevated NfL (β = −0.12, p < 0.05).

Genetic predisposition for immune activation might cause unfavorable immune response in early AD.

High genetic risk relates to cerebrospinal fluid (CSF) immune markers amid evident neurodegenerationImmune polygenic risk scores (PRSs) capture genotype‐phenotype associations in Alzheimer's disease (AD) immune activationAD PRSs and immune phenotype had an opposite relationship of the phenotype PRSsImportance of specific genetic predispositions in early AD immune phenotypes

High genetic risk relates to cerebrospinal fluid (CSF) immune markers amid evident neurodegeneration

Immune polygenic risk scores (PRSs) capture genotype‐phenotype associations in Alzheimer's disease (AD) immune activation

AD PRSs and immune phenotype had an opposite relationship of the phenotype PRSs

Importance of specific genetic predispositions in early AD immune phenotypes

## Linked entities

- **Proteins:** LOC105211155 (uncharacterized LOC105211155), CX3CL1 (C-X3-C motif chemokine ligand 1)
- **Diseases:** Alzheimer's disease (MONDO:0004975)

## Full-text entities

- **Genes:** CLU (clusterin) [NCBI Gene 1191] {aka AAG4, APO-J, APOJ, CLI, CLU1, CLU2}, NEFL (neurofilament light chain) [NCBI Gene 4747] {aka CMT1F, CMT2E, CMTDIG, NF-L, NF68, NFL}, CHI3L1 (chitinase 3 like 1) [NCBI Gene 1116] {aka ASRT7, CGP-39, GP-39, GP39, HC-gp39, HCGP-3P}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, CX3CL1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 6376] {aka ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT}
- **Diseases:** neurodegeneration (MESH:D019636), AD (MESH:D000544), autoimmune diseases (MESH:D001327)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12789877/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12789877/full.md

## References

73 references — full list in the complete paper: https://tomesphere.com/paper/PMC12789877/full.md

---
Source: https://tomesphere.com/paper/PMC12789877